Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MLNR | O43193 | 1/20 | 0.53 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.53 |
| ▸ | PGR | P06401 | 1/20 | 0.53 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.53 |
| ▸ | DRD2 | P14416 | 1/20 | 0.53 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.53 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.53 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.53 |
| ▸ | CNR1 | P21554 | 1/20 | 0.53 |
| ▸ | DRD1 | P21728 | 1/20 | 0.53 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | HRH2 | P25021 | 1/20 | 0.53 |
| ▸ | HTR2C | P28335 | 1/20 | 0.53 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.53 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.53 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17166926 | 0.98 | MLNR (0.52) | MLNRNR1I2PGRADRB1ADORA3 | |
| SCHEMBL18070770 | 0.97 | MLNR (0.55) | MLNRNR1I2PGRADRB1ADORA3 | |
| SCHEMBL12414885 | 0.97 | MLNR (0.54) | MLNRNR1I2PGRADRB1ADORA3 | |
| SCHEMBL12414861 | 0.94 | PRMT1 (0.52) | MLNRNR1I2PGRADRB1ADORA3 | |
| SCHEMBL15026320 | 0.91 | MLNR (0.64) | MLNRNR1I2PGRADRB1ADORA3 | |
| SCHEMBL10033462 | 0.91 | MLNR (0.64) | MLNRNR1I2PGRADRB1ADORA3 | |
| SCHEMBL821199 | 0.91 | MLNR (0.64) | MLNRNR1I2PGRADRB1ADORA3 | |
| SCHEMBL12414886 | 0.91 | PRMT1 (0.56) | MLNRNR1I2PGRADRB1ADORA3 | |
| SCHEMBL821486 | 0.91 | PRMT1 (0.52) | MLNRNR1I2PGRADRB1ADORA3 | |
| SCHEMBL23269836 | 0.90 | MLNR (0.57) | MLNRNR1I2PGRADRB1ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9156529-B2 | Method of making a lithographic printing plate | AGFA GRAPHICS NV (BE) | 2015-10-13 | — | — | US | disclosed |
| US-8778590-B2 | Lithographic printing plate precursor | AGFA GRAPHICS NV (BE) | 2014-07-15 | — | — | US | disclosed |
| US-8632950-B2 | Cyanine dyes and lithographic printing plate precursors comprising such dyes | AGFA GRAPHICS NV (BE) | 2014-01-21 | — | — | US | disclosed |
| US-20120208126-A1 | NOVEL CYANINE DYES AND LITHOGRAPHIC PRINTING PLATE PRECURSORS COMPRISING SUCH DYES | AGFA GRAPHICS NV (BE) | 2012-08-16 | — | — | US | disclosed |
| US-20110287364-A1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR | AGFA GRAPHICS NV (BE) | 2011-11-24 | — | — | US | disclosed |
| US-20110165518-A1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR | AGFA GRAPHICS NV (BE) | 2011-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120208126-A1 | NOVEL CYANINE DYES AND LITHOGRAPHIC PRINTING PLATE PRECURSORS COMPRISING SUCH DYES | LCP1, MLN, PRCP | MLNR 168/4885NR1I2 1181/4885PGR 2888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.